TECHNOLOGY
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
TechCrunchWednesday, September 23, 2026 at 7:31 PM
RedScroll Brief
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
RedScroll Signal
- Impact
- High
- Category
- Technology
- Market relevance
- Moderate
- Why it matters
- Technology shifts change how people work, communicate, and build — often faster than policy can follow. The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s. Secondary effects may show up in markets and supply chains linked to Enveda and Technology.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Why it matters
Technology shifts change how people work, communicate, and build — often faster than policy can follow.
Background
TechCrunch reported on this under technology. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
TechCrunch published: Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Secondary effects may show up in markets and supply chains linked to Enveda and Technology.
More on
Related stories
- The Download: why AI’s latest breakthroughs and fears may be more hype than reality
MIT Technology ReviewTECHNOLOGY
- YouTube promises custom feeds and a lot more AI later this year
Ars TechnicaTECHNOLOGY
- New Anthropic, OpenAI models make same promise: A little more for a lot less money
Ars TechnicaTECHNOLOGY
- The Download: India’s smart glasses menace and AI’s trillion-dollar gamble
MIT Technology ReviewTECHNOLOGY
- The Download: investigating deaths at the US border’s “virtual wall”
MIT Technology ReviewTECHNOLOGY
- XPRIZE Wildfire winners spotted fires within 10 min—but couldn’t stop them
Ars TechnicaTECHNOLOGY
Source
TechCrunch
Original reporting by TechCrunch. RedScroll provides an extractive briefing only.